What can we do about patients presenting with myeloma and severe renal failure? Observations from the UK MERIT plasma exchange trial

Myeloma patients presenting with renal failure continue to have a poor prognosis despite significant advances in anti‐myeloma therapy. MERIT was a randomised clinical trial (RCT), set up to evaluate if mechanical reduction of elevated free light chain levels (FLC) would result in clinical benefit. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Behrens, Judith, Gaskin, Gill, Iggo, Neil, Barratt, Jonathan, Tighe, Jane, Soutar, Richard, Cook, Gordon, Drake, Mary, Morris, Curly, Drayson, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928667/
https://www.ncbi.nlm.nih.gov/pubmed/36819186
http://dx.doi.org/10.1002/jha2.620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928667/
https://www.ncbi.nlm.nih.gov/pubmed/36819186
http://dx.doi.org/10.1002/jha2.620

Ejemplares similares